Knowles Julius 4
4 · Keros Therapeutics, Inc. · Filed Jan 20, 2023
Insider Transaction Report
Form 4
Knowles Julius
Director
Transactions
- Purchase
Common Stock
2020-04-13$20.98/sh+1,191$24,987→ 1,191 total
Holdings
- 232,727(indirect: See footnote)
Common Stock
- 341,574(indirect: See footnote)
Common Stock
Footnotes (2)
- [F1]The securities are held by Partners Innovation Fund, LLC ("PIF I"). Partners Innovation Fund, LLC ("Partners GP I") is the ultimate general partner of PIF I. The Reporting Person, a member of the board of directors of the Issuer, is a partner of Partners GP I and as a result, may be deemed to share voting and investment power with respect to the shares held by PIF I.
- [F2]The securities are held by Partners Innovation Fund II, L.P. ("PIF II"). Partners Innovation Fund II, LLC ("Partners GP II") is the ultimate general partner of PIF II. The Reporting Person, a member of the board of directors of the Issuer, is a partner of Partners GP II and as a result, may be deemed to share voting and investment power with respect to the shares held by PIF II.